Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-06T06:47:32.618Z Has data issue: false hasContentIssue false

An audit of clinical practice in an ACT team against NICE guidelines in schizophrenia

Published online by Cambridge University Press:  01 July 2007

Rob Macpherson*
Affiliation:
Consultant Psychiatrist, Wotton Lawn Hospital, Gloucester
Nicola Hovey
Affiliation:
Audit Manager, Gloucestershire NHS Partnership Trust, Rikenel, Montpellier, Gloucester
Krishen Ranganath
Affiliation:
Senior House Officer in Psychiatry, Wotton Lawn Hospital
Amjad Uppal
Affiliation:
Senior House Officer in Psychiatry, Wotton Lawn Hospital
Andrew Thompson
Affiliation:
Psychiatrist, ORYGEN Youth Health, Parkville, Melbourne, Australia
*
Correspondence to: Rob Macpherson, Wotton Lawn Hospital, Horton Road, Gloucester GL1 3WL. E-mail: [email protected]
Get access

Abstract

Aims and method: We audited the caseload of an Assertive Community Treatment (ACT) team against National Institute of Clinical Excellence (NICE) guidelines in the treatment of schizophrenia. Care coordinators rated the work carried out by the team on an audit tool. Results were compared to a case note audit completed 2 years earlier.

Results: 61 patients had a primary diagnosis of schizophrenia. Rates of compliance with NICE guidelines varied from 0% (provision of advance directive) to 85% (written information given, no antipsychotic polypharmacy). Compliance was greater than in the earlier audit.

Discussion: When refusal, lack of capacity or indication were taken account of, guidelines were generally adhered to. Although a useful benchmarking process and an opportunity to identify skill deficits in the team, our findings raised concerns about simplistic notions of guideline implementation, as a means to improve practice. Patient choice is an important consideration.

Type
Original Article
Copyright
Copyright © NAPICU 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dent, T.H. and Sadler, M. (2002) From guidance to practice: Why NICE is not enough. British Medical Journal. 324: 842845.CrossRefGoogle ScholarPubMed
Dopson, S., Locock, L., Chambers, D. and Gabbay, J. (2001) Implementation of evidence-based medicine: Evaluation of the Promoting Action on Clinical Effectiveness programme. Journal of Health Services Research and Policy. 6: 2331.CrossRefGoogle ScholarPubMed
Dyer, C. (2006) NICE faces legal challenge over restriction on dementia drugs. British Medical Journal. 333: 1085.CrossRefGoogle ScholarPubMed
Gaebel, W., Weinmann, S., Sartorius, N. et al. (2005) Schizophrenia practice guidelines: International survey and comparison. British Journal of Psychiatry. 187: 248255.CrossRefGoogle ScholarPubMed
Gilbody, S.M., House, A.O. and Sheldon, T.A. (2002) Psychiatrists in the UK do not use outcomes measures: National Survey. British Journal of Psychiatry. 180: 101103.CrossRefGoogle Scholar
National Institute for Clinical Excellence (2002) Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London.Google Scholar
Rowlands, P. (2004) The NICE schizophrenia guidelines: The challenge of implementation. Advances in Psychiatric Treatment. 10: 403412.CrossRefGoogle Scholar
Sheldon, T.A., Cullum, N., Dawson, D. et al. (2004) What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients’ notes and interviews. British Medical Journal. 329(7473): 999.CrossRefGoogle ScholarPubMed
Slade, M. (2002) What outcomes to measure in routine mental health services and how to assess them–a systematic review. Australia and New Zealand Journal of Psychiatry. 36(6): 743753.CrossRefGoogle ScholarPubMed
UK 700 Group (1999) Predictors of quality of life in people with severe mental illness. Study methodology with baseline analysis in the UK 700 trial. British Journal of Psychiatry. 175: 426432.CrossRefGoogle Scholar